For immediate release
Results for the year ended
Record results ahead of expectations, positive outlook
Financial summary:
|
|
2025 £m |
2024 £m |
Growth |
|
Revenue |
194.0 |
192.6 |
1% |
|
Adjusted operating profit* |
26.2 |
24.5 |
7% |
|
Adjusted operating margin %* |
13.5% |
12.7% |
80bps |
|
Adjusted profit before tax |
25.1 |
22.7 |
11% |
|
Adjusted basic earnings per share (pence)* |
42.3p |
38.6p |
10% |
|
Cash generated from operations |
29.2 |
25.7 |
14% |
|
Closing cash |
22.9 |
13.7 |
67% |
|
Statutory performance: |
|
|
|
|
Operating profit |
24.5 |
22.8 |
7% |
|
Profit before tax |
23.3 |
20.9 |
11% |
|
Basic earnings per share (pence) |
39.3p |
35.8p |
10% |
Group highlights:
· The Group delivered record revenue, profit and margin.
· Revenue up 1% to
· Adjusted operating margin* up 80 bps to 13.5% (2024: 12.7%), with margin progress across all three divisions.
· Cash generated from operations of
· Post period end, the Group announced the acquisition of
· Recommended final dividend of
· Capital Markets Event to be held in the second half of FY2026.
* See notes 1, 2 and 3 for definitions and reconciliations.
Commenting on the performance and outlook, Hooman Caman Javvi, Chief Executive, said:
"Porvair delivered record revenue, profit and margin in 2025, despite mixed trading conditions across our end markets. As expected, aerospace demand increased in the second half of the year, while petrochemical sales slowed, and industrials remained mixed. The laboratory end markets showed steady progress throughout the year, with environmental demand continuing to improve. Overall, the Group delivered another year of progress despite economic uncertainty and end-market inconsistency. This performance demonstrates the resilience and quality of our business, together with agility in managing near-term macro-economic uncertainty.
The Group's long-term fundamental demand drivers have not changed and Porvair remains well positioned to take advantage of tightening environmental regulation; the growth of analytical science; the need for clean water; the development of carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency. It is these trends, and Porvair's business model, that have driven the Group's consistent longer-term track record.
In the near-term there is much to look forward to in 2026, including welcoming the team at Drache to the Group; continuing to drive operational performance; new product introductions in aerospace, Seal Analytical and Porvair Life Sciences; the installation of our new manufacturing line for aluminium filtration; and industrial demand recovery. The Board remains committed to a strategy of organic and inorganic growth and is optimistic about the future."
For further information please contact:
|
|
|
+44 (0)1553 765 500 |
|
|
Hooman Caman Javvi, Chief Executive |
|
|
|
|
James Mills, Group Finance Director |
|
|
|
|
Burson Buchanan |
|
+44 (0)20 7466 5000 |
|
|
Charles Ryland / Stephanie Whitmore / |
|
|
|
An analyst briefing will take place at
Operating review
2025 was a year of record revenue, profit and margin, achieved despite variable demand patterns across our end markets. The Group reported 1% revenue growth (2% constant currency). Adjusted operating profit was 7% ahead of the prior year with an operating margin of 13.5%, an 80 bps improvement from 2024, with margin progress across all three divisions. Cash generation was strong, with closing cash of approximately
Trading was mixed across our end markets. As expected, we experienced stronger aerospace demand in the second half of the year, following a slower first six months. Industrial demand was mixed, with nuclear sales growing, while petrochemical sales, which can be lumpy, had a stronger first half than second. The end market for aluminium and superalloys continued to show progress, while the auto, truck and agriculture end markets, which represent a smaller part of the Group, was lower. The laboratory end markets showed steady growth, with the environmental market improving.
Porvair serves a range of markets in different parts of the world and trading can be affected by both local and global events, such as the changing tariff landscape during 2025. The Group's manufacturing footprint mainly serves local customers. Despite variation in the end markets in a particular year, Porvair benefits from underlying growth trends that have not changed. Our decentralised management structure is helpful in volatile trading conditions, enabling key commercial decisions to be made closer to customers and suppliers. The benefit of the Group's diverse operating spread is shown in the consistent long-term track record, despite inconsistent demand across end markets.
Since joining the Group, I have visited all our locations and spent time with our highly talented global teams over the year. We have implemented various changes to the way the team works together. In order to enhance our execution and increase momentum, we have formed an Executive Committee responsible for the management of the Group, consisting of the Executive Directors and key members of the senior leadership team. We also added a central resource during the year to support M&A activities and proactively manage the pipeline.
During the year, we reviewed the strategy and business model, continuing to build on the many strengths of the Group, while further accelerating momentum to deliver long-term value. This covers the approach to market, capital allocation priorities, innovation, operational performance, and, underpinning all of what we do, continuing to invest in our people and talent development across the business. I am confident that Porvair is well-placed to deliver sustainable growth for stakeholders.
Track record
Porvair's performance has remained relatively consistent over many years and the Group's track record for growth, cash generation and investment is:
|
|
5 years |
10 years |
15 years |
|
Revenue - base year |
|
|
|
|
Revenue CAGR** |
8% |
7% |
8% |
|
Earnings per share CAGR** |
16% |
10% |
14% |
|
Adjusted earnings per share CAGR** |
14% |
11% |
15% |
|
** Compound annual growth rate |
|
|
|
|
|
5 years |
10 years |
15 years |
|
|
£m |
£m |
£m |
|
Cash generated from operations |
120.4 |
191.4 |
248.4 |
|
Investment in acquisitions and capital expenditure |
54.8 |
105.3 |
127.0 |
This longer-term growth record gives the Board confidence in the Group's capabilities and is the basis for capital allocation and planning decisions.
Strategy and business model
Porvair's strategic purpose is the development of specialist filtration, laboratory and environmental technology businesses for the benefit of all stakeholders. Principal measures of success include consistent earnings growth and selected ESG measures. During the year, the strategy has been reviewed, continuing to build on the many strengths of the Group, while further accelerating momentum to deliver long-term value. This covers the approach to market, capital allocation priorities, innovation, operational performance, and, underpinning all of what we do, continuing to invest in our people and talent development across the business. Porvair will host a capital markets event in the second half of the year to provide more detail.
The Group is positioned to benefit from global trends as outlined above.
Porvair businesses have certain key characteristics in common:
· specialist design, engineering or commercial skills are required;
· product use and replacement is mandated by regulation, quality accreditation or a maintenance cycle; and
· products are typically designed into a system that will have a long life-cycle and must perform to a given specification.
Orders are won by offering the best technical solutions or commercial service at an acceptable cost. Technical expertise is necessary in all markets served. New products are often adaptations of existing designs with attributes validated in our own test and measurement laboratories. Experience in specific markets and applications is valuable in building customer confidence. Domain knowledge is important, as is deciding where to direct resources.
This leads the Group to:
· focus on markets with long-term growth potential;
· look for applications where product use is mandated and replacement demand is regular;
· make new product development a core business activity;
· establish geographic presence where end-markets require; and
· invest in both organic and inorganic growth.
Therefore:
· Porvair focuses on three operating divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality. All have clear long-term growth drivers;
· our products typically reduce emissions or protect complex downstream systems and, as a result, are replaced regularly. A high proportion of our annual revenue is from repeat orders;
· through a focus on new product development, we aim to generate growth rates in excess of the underlying market through cycle. Where possible, we build intellectual property around our product developments;
· our geographic presence follows the markets we serve. In the last twelve months: 44% of revenue was in the Americas; 27% in Continental Europe; 16% in Asia; 11% in the UK; and 2% in Africa. The Group has plants in the US, UK, Belgium, Germany, Hungary, the Netherlands, India and China. In the last twelve months: 45% of revenue was manufactured in the US; 26% in the UK; 25% in Continental Europe; and 4% in Asia; and
· we aim to meet dividend and investment needs from free cash flow and modest borrowing facilities.
Environmental, Social and Governance ("ESG")
The Board understands that responsible business development is essential for creating long-term value for stakeholders. Most of the products made by Porvair are used to the benefit of the environment. Our water analysis equipment measures contamination levels in water. Industrial filters are typically needed to reduce emissions or improve efficiency. Aerospace filters improve safety and reliability. Nuclear filters confine fissile materials. Metal Melt Quality filters reduce waste and help improve the strength-to-weight ratio of metal components.
Divisional review
Aerospace & Industrial
|
|
2025 |
|
2024 |
|
Growth |
|
|
£m |
|
£m |
|
% |
|
Revenue |
83.7 |
|
84.2 |
|
(1) |
|
Adjusted operating profit* |
11.9 |
|
11.8 |
|
1 |
|
Adjusted operating margin %* |
14.2% |
|
14.0% |
|
20bps |
|
Operating profit |
11.1 |
|
10.8 |
|
3 |
* See notes 1 and 2 for definitions and reconciliations.
The Aerospace & Industrial division designs and manufactures a wide range of specialist filtration products, demand for which is driven by customers seeking better engineered, cleaner, safer or more efficient operations. Differentiation is achieved through design engineering; the development of intellectual property; quality accreditations; and customer service. The division operates from sites in the UK, US, the Netherlands, Belgium and India, and its sales are global.
Revenue in the year declined by 1% (flat on constant currency). Aerospace revenue grew by 4% for the full year, despite being 8% lower in the first half. Petrochemical sales, which can be lumpy, were 6% lower compared with a strong comparator last year. The European petrochemical market is expected to remain subdued in 2026. EFC, which was acquired in
Laboratory
|
|
2025 |
|
2024 |
|
Growth |
|
|
£m |
|
£m |
|
% |
|
Revenue |
66.9 |
|
64.4 |
|
4 |
|
Adjusted operating profit* |
10.9 |
|
9.5 |
|
15 |
|
Adjusted operating margin %* |
16.3% |
|
14.8% |
|
150bps |
|
Operating profit |
10.0 |
|
8.7 |
|
15 |
* See notes 1 and 2 for definitions and reconciliations.
The Laboratory division has two operating businesses: Porvair Life Sciences (including Porvair Sciences, Finneran, Kbiosystems and Ratiolab) and Seal Analytical. The division operates from sites in the UK, US, Germany, Hungary, the Netherlands and China, and its sales are global.
· Porvair Life Sciences manufactures laboratory filters, small instruments and associated consumables, for which demand is driven by sample preparation in analytical laboratories. Differentiation is achieved through proprietary manufacturing capabilities; control of filtration media; and customer service.
· Seal Analytical supplies instruments and consumables to environmental laboratories, for which demand is driven by water quality regulations. Differentiation is achieved through consistent new product development focused on improving detection limits and improving laboratory automation.
Revenue growth of 4% (5% on constant currency) was driven by steady progress across the end markets, with the environmental end market growing 9% over prior year. Several new product developments in Seal Analytical, Porvair Sciences and Kbiosystems were launched during the year, with good early interest from the market, which should be promising for the coming year and beyond. The adjusted operating profit grew 15%, with a 150bps improvement in operating margin, driven by improved operational focus and continued investment in automation and capacity across the businesses.
Metal Melt Quality
|
|
2025 |
|
2024 |
|
Growth |
|
|
£m |
|
£m |
|
% |
|
Revenue |
43.4 |
|
44.1 |
|
(1) |
|
Adjusted operating profit* |
6.6 |
|
5.9 |
|
12 |
|
Adjusted operating margin %* |
15.2% |
|
13.4% |
|
180bps |
|
Operating profit |
6.6 |
|
5.9 |
|
12 |
* See notes 1 and 2 for definitions and reconciliations.
The Metal Melt Quality division manufactures filters for molten aluminium, ductile iron and nickel-cobalt alloys. It has a well-differentiated product range based on patented products and extensive experience in melt quality assessment. Following the acquisition of Drache in
Revenue declined 1% (1% up on constant currency), while adjusted operating profit increased by 12%. Demand within the auto, truck and agriculture end markets, which represent a smaller part of the Group, was lower, although sales picked up in the second half of the year. This reduction was partially offset by increased aluminium cast house demand and strong demand for superalloys. The operations in China continued to improve in a year affected by increased geopolitical uncertainty and the current tariff environment, and delivered modest profit growth on prior year.
The
On
These investments will position the Group well to benefit from growing global demand for aluminium filtration. This global growth trend is underpinned by the infinite recyclability of aluminium; its strength-to-weight benefits for use in transportation; the replacement of plastic and steel with aluminium; and the energy efficiency of cast house recycling compared to primary production.
Dividends
The Board is recommending a final dividend of 4.5 pence per share, at a value of £2.1m (2024:
Current trading and outlook
Porvair delivered record revenue, profit and margin in 2025, despite mixed trading conditions across our end markets. As expected, aerospace demand increased in the second half of the year, while petrochemical sales slowed, and industrials remained mixed. The laboratory end markets showed steady progress throughout the year, with environmental demand continuing to improve. Overall, the Group delivered another year of progress despite economic uncertainty and end-market inconsistency. This performance demonstrates the resilience and quality of our business, together with agility in managing near-term macro-economic uncertainty.
The Group's long-term fundamental demand drivers have not changed and Porvair remains well positioned to take advantage of tightening environmental regulation; the growth of analytical science; the need for clean water; the development of carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency. It is these trends, and Porvair's business model, that have driven the Group's consistent longer-term track record.
In the near-term there is much to look forward to in 2026, including welcoming the team at Drache to the Group; continuing to drive operational performance; new product introductions in aerospace, Seal Analytical and Porvair Life Sciences; the installation of our new manufacturing line for aluminium filtration; and industrial demand recovery. The Board remains committed to a strategy of organic and inorganic growth and is optimistic about the future.
Hooman Caman Javvi
Group Chief Executive
Financial review
Group results
|
|
2025 |
|
2024 |
|
Growth |
|
|
£m |
|
£m |
|
% |
|
Revenue |
194.0 |
|
192.6 |
|
1 |
|
Operating profit |
24.5 |
|
22.8 |
|
7 |
|
Profit before tax |
23.3 |
|
20.9 |
|
11 |
|
Profit after tax |
18.2 |
|
16.6 |
|
10 |
Revenue was 1% higher on a reported currency basis and 2% higher at constant currency (see note 1). Operating profit was
Alternative performance measures - Group profit
The Group presents alternative performance measures to support the understanding of its trading performance (see note 1).
Adjusted profit excludes £1.6m (2024:
|
|
2025 |
|
2024 |
|
Growth |
|
|
£m |
|
£m |
|
% |
|
Adjusted operating profit |
26.2 |
|
24.5 |
|
7 |
|
Adjusted profit before tax |
25.1 |
|
22.7 |
|
11 |
|
Adjusted profit after tax |
19.5 |
|
17.9 |
|
9 |
Impact of exchange rate movements on performance
The international nature of the Group's business means that relative movements in exchange rates can affect reported performance. The rates used for translating the results of overseas operations were:
|
|
2025 |
|
2024 |
|
Average rate for translating the results: |
|
|
|
|
US$ denominated operations |
|
|
|
|
Euro denominated operations |
|
|
|
|
Closing rate for translating the balance sheet: |
|
|
|
|
US$ denominated operations |
|
|
|
|
Euro denominated operations |
|
|
|
During the year, the Group experienced a
During the year, the Group sold US$24.9m (2024:
Net finance costs
Net finance costs comprise interest income on deposits, interest on borrowings, lease liabilities, and the Group's retirement benefit obligations, together with the cost of unwinding discounts on provisions. The Group also incurs undrawn commitment fees on the Group's available banking facilities. Net finance costs of £1.2m (2024:
Tax
The total Group tax charge for the year was £5.1m (2024:
The Group has current tax provisions of £0.2m (2024:
The Group carries a deferred tax asset of £nil (2024:
Cash flow, cash and net debt
The table below summarises the cash flow for the year:
|
|
2025 |
|
2024 |
|
|
£m |
|
£m |
|
Operating cash flow before working capital |
33.0 |
|
31.7 |
|
Working capital movement |
(1.6) |
|
(3.8) |
|
Post-employment benefits |
(2.2) |
|
(2.2) |
|
Cash generated from operations |
29.2 |
|
25.7 |
|
Interest |
(0.2) |
|
(0.7) |
|
Tax |
(5.1) |
|
(3.4) |
|
Capital expenditure |
(7.7) |
|
(5.1) |
|
|
16.2 |
|
16.5 |
|
Acquisitions (net of cash acquired) |
- |
|
(10.2) |
|
Share issue proceeds |
- |
|
0.6 |
|
Purchase of |
(0.9) |
|
(0.7) |
|
Dividends |
(3.0) |
|
(2.8) |
|
Repayment of lease liabilities |
(3.2) |
|
(3.5) |
|
Increase/(decrease) in cash |
9.1 |
|
(0.1) |
|
|
|
|
|
|
Net cash/(debt) reconciliation |
2025 |
|
2024 |
|
|
£m |
|
£m |
|
Net (debt)/cash at 1 December |
(3.7) |
|
0.7 |
|
Increase/(decrease) in cash |
9.1 |
|
(0.1) |
|
Decrease/(increase) in lease liabilities |
3.2 |
|
(4.4) |
|
Exchange |
(0.2) |
|
0.1 |
|
Net cash/(debt) at 30 November |
8.4 |
|
(3.7) |
|
Cash and cash equivalents |
22.9 |
|
13.7 |
|
Lease liabilities |
(14.5) |
|
(17.4) |
|
Net cash/(debt) at 30 November |
8.4 |
|
(3.7) |
Cash generation is central to the Group's business model. Cash generated from operations was £29.2m (2024:
Capital expenditure on property, plant and equipment was
The Group started the year with cash and cash equivalents of
Bank borrowings at
Return on capital employed
The Group's return on capital employed was 14.4% (2024: 14.6%). Excluding the impact of goodwill, acquired intangible assets and retirement benefit obligations, the return on operating capital employed was 34.5% (2024: 36.0%).
Retirement benefit obligations
Retirement benefit obligations measured in accordance with IAS 19 Employee Benefits were £3.3m (2024:
The Plan's triennial actuarial valuation was completed in the year based on the position at
Total equity
Total equity at
Events after the reporting date
On 12
Further detail is provided in note 7.
Finance and treasury policy
The treasury function at Porvair is managed centrally, under Board supervision. It seeks to limit the Group's trading exposure to currency movements. The Group does not hedge against the impact of exchange rate movements on the translation of profits and losses of overseas operations. The Group finances its operations through share capital, retained profits and, when required, bank borrowings. It has adequate facilities to finance its current operations and capital plans for the foreseeable future.
James Mills
Group Finance Director
Consolidated income statement
For the year ended 30 November
|
|
|
2025 |
|
2024 |
|
Continuing operations |
Note |
£'000 |
|
£'000 |
|
Revenue |
1,2 |
193,977 |
|
192,639 |
|
Cost of sales |
|
(125,320) |
|
(127,534) |
|
Gross profit |
|
68,657 |
|
65,105 |
|
Distribution costs |
|
(3,722) |
|
(3,524) |
|
Administrative expenses |
|
(40,471) |
|
(38,784) |
|
Adjusted operating profit |
1,2 |
26,236 |
|
24,540 |
|
Adjustments: |
|
|
|
|
|
Amortisation of acquired intangible assets |
|
(1,633) |
|
(1,743) |
|
Other acquisition-related costs |
|
(139) |
|
- |
|
Operating profit |
1,2 |
24,464 |
|
22,797 |
|
Finance income |
|
93 |
|
51 |
|
Finance costs |
|
(1,267) |
|
(1,936) |
|
Profit before tax |
|
23,290 |
|
20,912 |
|
Adjusted income tax expense |
1 |
(5,538) |
|
(4,751) |
|
Adjustments: |
|
|
|
|
|
Tax effect of adjustments to operating profit |
|
418 |
|
441 |
|
Income tax expense |
|
(5,120) |
|
(4,310) |
|
Profit for the year |
|
18,170 |
|
16,602 |
|
Profit attributable to: |
|
|
|
|
|
- Owners of the parent |
|
18,149 |
|
16,479 |
|
- Non-controlling interests |
|
21 |
|
123 |
|
Profit for the year |
|
18,170 |
|
16,602 |
|
|
|
|
|
|
|
Earnings per share (basic) |
3 |
39.3p |
|
35.8p |
|
Earnings per share (diluted) |
3 |
39.3p |
|
35.8p |
|
|
|
|
|
|
|
Adjusted earnings per share (basic) |
3 |
42.3p |
|
38.6p |
|
Adjusted earnings per share (diluted) |
3 |
42.2p |
|
38.6p |
Consolidated statement of comprehensive income
For the year ended 30 November
|
|
|
2025 £'000 |
|
2024 £'000 |
|
|
Profit for the year |
|
18,170 |
|
16,602 |
|
|
Other comprehensive income/(loss) |
|
|
|
|
|
|
Items that will not be reclassified to profit and loss: |
|
|
|
|
|
|
Actuarial gain/(loss) in defined benefit pension plans net of tax |
|
456 |
|
(64) |
|
|
Items that may be subsequently reclassified to profit and loss: |
|
||||
|
Exchange loss on translation of foreign subsidiaries |
|
(1,110) |
|
(1,566) |
|
|
Total other comprehensive loss for the year |
|
(654) |
|
(1,630) |
|
|
Total comprehensive income for the year |
|
17,516 |
|
14,972 |
|
|
Comprehensive income attributable to: |
|
|
|
|
|
|
- Owners of the parent |
|
17,495 |
|
14,849 |
|
|
- Non-controlling interests |
|
21 |
|
123 |
|
|
Total comprehensive income for the year |
|
17,516 |
|
14,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated balance sheet
As at 30 November
|
|
Note |
2025 £'000 |
|
2024 £'000 |
|
Non-current assets |
|
|
|
|
|
Property, plant and equipment |
|
32,630 |
|
29,327 |
|
Right-of-use assets |
|
13,466 |
|
16,433 |
|
Goodwill and other intangible assets |
|
87,926 |
|
89,792 |
|
Deferred tax asset |
|
- |
|
84 |
|
|
|
134,022 |
|
135,636 |
|
Current assets |
|
|
|
|
|
Inventories |
|
32,955 |
|
31,969 |
|
Trade and other receivables |
|
33,690 |
|
31,665 |
|
Derivative financial instruments |
|
32 |
|
7 |
|
Cash |
|
22,873 |
|
15,838 |
|
|
|
89,550 |
|
79,479 |
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
|
(29,538) |
|
(27,408) |
|
Bank overdrafts |
|
- |
|
(2,097) |
|
Current tax liabilities |
|
(242) |
|
(1,572) |
|
Lease liabilities |
|
(2,445) |
|
(2,487) |
|
Derivative financial instruments |
|
- |
|
(40) |
|
Provisions |
5 |
(2,982) |
|
(3,256) |
|
|
|
(35,207) |
|
(36,860) |
|
Net current assets |
|
54,343 |
|
42,619 |
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
Deferred tax liability |
|
(4,933) |
|
(3,704) |
|
Retirement benefit obligations |
|
(3,335) |
|
(5,897) |
|
Other payables |
|
(45) |
|
(85) |
|
Lease liabilities |
|
(11,986) |
|
(14,969) |
|
Provisions |
5 |
(385) |
|
(346) |
|
|
|
(20,684) |
|
(25,001) |
|
Net assets |
|
167,681 |
|
153,254 |
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
Share capital |
|
930 |
|
930 |
|
Share premium account |
|
38,421 |
|
38,407 |
|
Cumulative translation reserve |
|
8,149 |
|
9,259 |
|
Retained earnings |
|
120,032 |
|
104,530 |
|
Equity attributable to owners of the parent |
|
167,532 |
|
153,126 |
|
Non-controlling interests |
|
149 |
|
128 |
|
Total equity |
|
167,681 |
|
153,254 |
Consolidated cash flow statement
For the year ended 30 November
|
|
Note |
2025 £'000 |
|
2024 £'000 |
|
Cash flows from operating activities |
|
|
|
|
|
Cash generated from operations |
6 |
29,214 |
|
25,744 |
|
Interest paid |
|
(281) |
|
(739) |
|
Tax paid |
|
(5,100) |
|
(3,488) |
|
Net cash generated from operating activities |
|
23,833 |
|
21,517 |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
Interest received |
|
91 |
|
49 |
|
Acquisition of subsidiaries (net of cash acquired) |
|
(37) |
|
(10,204) |
|
Purchase of property, plant and equipment |
|
(7,523) |
|
(4,839) |
|
Purchase of intangible assets |
|
(201) |
|
(289) |
|
Proceeds from sale of property, plant and equipment |
|
33 |
|
5 |
|
Proceeds from sale of share capital of non-controlling interests |
|
- |
|
5 |
|
Net cash used in investing activities |
|
(7,637) |
|
(15,273) |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
Proceeds from issue of ordinary shares |
|
14 |
|
632 |
|
Purchase of Employee Benefit Trust shares |
|
(885) |
|
(724) |
|
Proceeds of loans and borrowings |
|
- |
|
10,721 |
|
Repayments of loans and borrowings |
|
- |
|
(10,721) |
|
Dividends paid to shareholders |
4 |
(2,953) |
|
(2,811) |
|
Repayments of lease liabilities |
|
(3,237) |
|
(3,485) |
|
Net cash used in financing activities |
|
(7,061) |
|
(6,388) |
|
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents |
|
9,135 |
|
(144) |
|
Effects of exchange rate changes |
|
(3) |
|
(167) |
|
|
|
9,132 |
|
(311) |
|
Cash and cash equivalents at 1 December |
|
13,741 |
|
14,052 |
|
Cash and cash equivalents at 30 November |
|
22,873 |
|
13,741 |
Reconciliation of net cash flow to movement in net cash/(debt)
|
|
|
2025 £'000 |
|
2024 £'000 |
|
|
|
|
|
|
|
Net (debt)/cash at 1 December |
|
(3,715) |
|
653 |
|
Increase/(decrease) in cash and cash equivalents |
|
9,135 |
|
(144) |
|
Net movement in borrowings |
|
- |
|
- |
|
Lease liabilities additions, exits and accretion of interest |
|
759 |
|
(4,994) |
|
Lease liabilities acquired |
|
- |
|
(2,044) |
|
Lease liabilities interest incurred |
|
(741) |
|
(811) |
|
Lease liabilities repaid |
|
3,237 |
|
3,485 |
|
Effects of exchange rate changes |
|
(233) |
|
140 |
|
Net cash/(debt) at 30 November |
|
8,442 |
|
(3,715) |
|
Cash and cash equivalents |
|
22,873 |
|
13,741 |
|
Lease liabilities |
|
(14,431) |
|
(17,456) |
|
Net cash/(debt) at 30 November |
|
8,442 |
|
(3,715) |
Consolidated statement of changes in equity
For the year ended 30 November
|
|
Share capital £'000 |
Share premium account £'000 |
Cumulative translation reserve £'000 |
Retained earnings £'000 |
Non-controlling interest £'000 |
Total equity £'000 |
|
At 1 December 2023 |
927 |
37,778 |
10,825 |
90,908 |
- |
140,438 |
|
Profit for the year |
- |
- |
- |
16,479 |
123 |
16,602 |
|
Other comprehensive loss |
- |
- |
(1,566) |
(64) |
- |
(1,630) |
|
Total comprehensive income for the year |
- |
- |
(1,566) |
16,415 |
123 |
14,972 |
|
Purchase of own shares (held in trust) |
- |
- |
- |
(724) |
- |
(724) |
|
Issue of ordinary share capital |
3 |
629 |
- |
- |
- |
632 |
|
Share-based payments (net of tax) |
- |
- |
- |
742 |
- |
742 |
|
Changes in non-controlling interests |
- |
- |
- |
- |
5 |
5 |
|
Dividends paid |
- |
- |
- |
(2,811) |
- |
(2,811) |
|
At 30 November 2024 |
930 |
38,407 |
9,259 |
104,530 |
128 |
153,254 |
|
|
|
|
|
|
|
|
|
Profit for the year |
- |
- |
- |
18,149 |
21 |
18,170 |
|
Other comprehensive loss |
- |
- |
(1,110) |
456 |
- |
(654) |
|
Total comprehensive income for the year |
- |
- |
(1,110) |
18,605 |
21 |
17,516 |
|
Purchase of own shares (held in trust) |
- |
- |
- |
(885) |
- |
(885) |
|
Issue of ordinary share capital |
- |
14 |
- |
- |
- |
14 |
|
Share-based payments (net of tax) |
- |
- |
- |
735 |
- |
735 |
|
Changes in non-controlling interests |
- |
- |
- |
- |
- |
- |
|
Dividends paid |
- |
- |
- |
(2,953) |
- |
(2,953) |
|
At 30 November 2025 |
930 |
38,421 |
8,149 |
120,032 |
149 |
167,681 |
Notes
1. Alternative performance measures
Alternative performance measures are used by the Directors and management to monitor business performance internally and exclude certain cash and non-cash items to reflect a more consistent measure of underlying trading performance. The Directors believe that disclosing such non-IFRS measures enables a reader to isolate and evaluate the impact of such items on results and allows for a fuller understanding of performance from year-to-year. Alternative performance measures may not be directly comparable with other similarly titled measures used by other companies.
Alternative revenue measures
|
|
2025 |
|
2024 |
|
Growth |
|
Aerospace & Industrial |
£'000 |
|
£'000 |
|
% |
|
Revenue at constant currency |
82,333 |
|
82,215 |
|
- |
|
Exchange |
1,343 |
|
2,002 |
|
|
|
Revenue as reported |
83,676 |
|
84,217 |
|
(1) |
|
|
|
|
|
|
|
|
Laboratory |
|
|
|
|
|
|
Revenue at constant currency |
64,599 |
|
61,444 |
|
5 |
|
Exchange |
2,285 |
|
2,919 |
|
|
|
Revenue as reported |
66,884 |
|
64,363 |
|
4 |
|
|
|
|
|
|
|
|
Metal Melt Quality |
|
|
|
|
|
|
Revenue at constant currency |
40,706 |
|
40,291 |
|
1 |
|
Exchange |
2,711 |
|
3,768 |
|
|
|
Revenue as reported |
43,417 |
|
44,059 |
|
(1) |
|
|
|
|
|
|
|
|
Group |
|
|
|
|
|
|
Revenue at constant currency |
187,638 |
|
183,950 |
|
2 |
|
Exchange |
6,339 |
|
8,689 |
|
|
|
Revenue as reported |
193,977 |
|
192,639 |
|
1 |
Revenue at constant currency is derived from translating overseas subsidiaries results at fixed constant exchange rates. In 2025 and 2024, the rates used were US$1.40:£1 and €1.20:£1, compared with reported rates of US$1.31:£1 (2024: US$1.28:£1) and €1.17:£1 (2024: €1.18:£1).
Alternative profit measures
A reconciliation of the Group's adjusted performance measures to the reported IFRS measures is presented below:
|
|
|
2025 |
|
|
|
2024 |
|
|
|
Adjusted |
Adjustments |
Reported |
|
Adjusted |
Adjustments |
Reported |
|
|
£'000 |
£'000 |
£'000 |
|
£'000 |
£'000 |
£'000 |
|
Operating profit |
26,236 |
(1,772) |
24,464 |
|
24,540 |
(1,743) |
22,797 |
|
Finance income |
93 |
- |
93 |
|
51 |
- |
51 |
|
Finance costs |
(1,267) |
- |
(1,267) |
|
(1,936) |
- |
(1,936) |
|
Profit before tax |
25,062 |
(1,772) |
23,290 |
|
22,655 |
(1,743) |
20,912 |
|
Income tax expense |
(5,538) |
418 |
(5,120) |
|
(4,751) |
441 |
(4,310) |
|
Profit for the year |
19,524 |
(1,354) |
18,170 |
|
17,904 |
(1,302) |
16,602 |
An analysis of adjusting items is given below:
|
|
2025 |
|
2024 |
|
Affecting operating profit: |
£'000 |
|
£'000 |
|
Amortisation of acquired intangible assets |
(1,633) |
|
(1,743) |
|
Other acquisition-related costs |
(139) |
|
- |
|
|
(1,772) |
|
(1,743) |
|
Affecting tax: |
|
|
|
|
Tax effect of adjustments to operating profit |
418 |
|
441 |
|
Total adjusting items |
(1,354) |
|
(1,302) |
Adjusted operating profit excludes:
· the amortisation of intangible assets arising on acquisition of businesses of £1.6m (2024: £1.7m); and
· other acquisition-related costs of £0.1m (2024: £nil) incurred in relation to the acquisition of the 100% share capital of Drache Umwelttechnik GmbH acquired in January 2026. Further details are disclosed in note 7.
Adjusted earnings before interest; tax; depreciation; and amortisation of intangible assets ("EBITDA")
The Group's adjusted EBITDA is determined as follows:
|
|
2025 |
|
2024 |
|
|
£'000 |
|
£'000 |
|
Operating profit |
24,464 |
|
22,797 |
|
Amortisation of acquired intangible assets |
1,633 |
|
1,743 |
|
Other acquisition-related costs |
139 |
|
- |
|
Adjusted operating profit |
26,236 |
|
24,540 |
|
Depreciation of property, plant and equipment |
3,763 |
|
3,576 |
|
Depreciation of right-of-use assets |
2,604 |
|
2,201 |
|
Amortisation of other intangible assets |
155 |
|
184 |
|
Impairment of property, plant and equipment |
- |
|
16 |
|
Adjusted EBITDA |
32,758 |
|
30,517 |
Return on capital employed
The Group uses two return measures to assess the return it makes on its investments:
· adjusted post tax return on capital employed of 14.4% (2024: 14.6%) is the tax adjusted operating profit as a percentage of the average capital employed. Capital employed is the average of the opening and closing Group net assets less the average of the opening and closing cash and cash equivalents, and borrowings; and
· adjusted post tax return on operating capital employed of 34.5% (2024: 36.0%) is calculated on the same basis except that the capital employed is adjusted to remove the average of the opening and closing goodwill; the average of opening and closing acquired intangible assets (net of deferred tax); and the opening and closing retirement benefit obligations (net of deferred tax) to give a measure of the operating capital.
2. Segment information
The chief operating decision maker has been identified as the Board of Directors. The Board of Directors has instructed the Group's internal reporting to be based around differences in products and services, in order to assess performance and allocate resources. The key profit measure used to assess the performance of each reportable segment is adjusted operating profit/(loss). Management has determined the operating segments based on this reporting.
As at 30 November 2025, the Group is organised on a worldwide basis into three operating segments:
1) Aerospace & Industrial - principally serving the aviation, and energy and industrial markets;
2) Laboratory - principally serving the bioscience and environmental laboratory instrument and consumables market; and
3) Metal Melt Quality - principally serving the global aluminium, iron foundry and superalloys markets.
Other Group operations' costs, assets and liabilities are included in the "Central" division. Central costs mainly comprise Group corporate costs, including new business development costs, some research and development costs and general financial costs. Central assets and liabilities mainly comprise Group retirement benefit obligations, tax assets and liabilities, cash and cash equivalents, and borrowings.
The segment results for the year ended 30 November 2025 are as follows:
|
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
Total segment revenue |
83,712 |
|
68,320 |
|
43,417 |
|
- |
|
195,449 |
|
Inter-segment revenue |
(36) |
|
(1,436) |
|
- |
|
- |
|
(1,472) |
|
Revenue |
83,676 |
|
66,884 |
|
43,417 |
|
- |
|
193,977 |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss) |
11,865 |
|
10,860 |
|
6,624 |
|
(3,113) |
|
26,236 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
Amortisation of acquired intangible assets |
(777) |
|
(856) |
|
- |
|
- |
|
(1,633) |
|
Other acquisition-related costs |
- |
|
- |
|
- |
|
(139) |
|
(139) |
|
Operating profit/(loss) |
11,088 |
|
10,004 |
|
6,624 |
|
(3,252) |
|
24,464 |
|
Finance income |
- |
|
- |
|
- |
|
93 |
|
93 |
|
Finance costs |
- |
|
- |
|
- |
|
(1,267) |
|
(1,267) |
|
Profit/(loss) before tax |
11,088 |
|
10,004 |
|
6,624 |
|
(4,426) |
|
23,290 |
The segment results for the year ended 30 November 2024 are as follows:
|
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
Total segment revenue |
84,266 |
|
65,840 |
|
44,059 |
|
- |
|
194,165 |
|
Inter-segment revenue |
(49) |
|
(1,477) |
|
- |
|
- |
|
(1,526) |
|
Revenue |
84,217 |
|
64,363 |
|
44,059 |
|
- |
|
192,639 |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss) |
11,804 |
|
9,503 |
|
5,917 |
|
(2,684) |
|
24,540 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
Amortisation of acquired intangible assets |
(958) |
|
(785) |
|
- |
|
- |
|
(1,743) |
|
Operating profit/(loss) |
10,846 |
|
8,718 |
|
5,917 |
|
(2,684) |
|
22,797 |
|
Finance income |
- |
|
- |
|
- |
|
51 |
|
51 |
|
Finance costs |
- |
|
- |
|
- |
|
(1,936) |
|
(1,936) |
|
Profit/(loss) before tax |
10,846 |
|
8,718 |
|
5,917 |
|
(4,569) |
|
20,912 |
The segment assets and liabilities at 30 November 2025 are as follows:
|
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
Segmental assets |
86,731 |
|
72,388 |
|
39,343 |
|
2,237 |
|
200,699 |
|
Cash |
- |
|
- |
|
- |
|
22,873 |
|
22,873 |
|
Total assets |
86,731 |
|
72,388 |
|
39,343 |
|
25,110 |
|
223,572 |
|
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities |
(26,096) |
|
(11,936) |
|
(6,452) |
|
(8,072) |
|
(52,556) |
|
Retirement benefit obligations |
- |
|
- |
|
- |
|
(3,335) |
|
(3,335) |
|
Bank overdrafts |
- |
|
- |
|
- |
|
- |
|
- |
|
Total liabilities |
(26,096) |
|
(11,936) |
|
(6,452) |
|
(11,407) |
|
(55,891) |
The segment assets and liabilities at 30 November 2024 are as follows:
|
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
Segmental assets |
87,154 |
|
73,447 |
|
36,477 |
|
2,199 |
|
199,277 |
|
Cash |
- |
|
- |
|
- |
|
15,838 |
|
15,838 |
|
Total assets |
87,154 |
|
73,447 |
|
36,477 |
|
18,037 |
|
215,115 |
|
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities |
(26,604) |
|
(12,585) |
|
(6,573) |
|
(8,105) |
|
(53,867) |
|
Retirement benefit obligations |
- |
|
- |
|
- |
|
(5,897) |
|
(5,897) |
|
Bank overdrafts |
- |
|
- |
|
- |
|
(2,097) |
|
(2,097) |
|
Total liabilities |
(26,604) |
|
(12,585) |
|
(6,573) |
|
(16,099) |
|
(61,861) |
Geographical analysis
|
|
2025 |
|
2024 |
||||
|
Revenue |
By destination £'000 |
|
By origin £'000 |
|
By destination £'000 |
|
By origin £'000 |
|
United Kingdom |
21,763 |
|
51,161 |
|
20,180 |
|
51,714 |
|
Continental Europe |
53,188 |
|
48,315 |
|
54,025 |
|
48,652 |
|
United States of America |
78,950 |
|
86,317 |
|
77,731 |
|
87,008 |
|
Other North America |
3,799 |
|
- |
|
4,926 |
|
- |
|
South America |
1,902 |
|
- |
|
1,826 |
|
- |
|
Asia |
31,184 |
|
8,184 |
|
31,359 |
|
5,265 |
|
Africa |
3,191 |
|
- |
|
2,592 |
|
- |
|
|
193,977 |
|
193,977 |
|
192,639 |
|
192,639 |
3. Earnings per share ("EPS")
|
|
2025 |
|
2024 |
|
||||
|
As reported
|
Earnings £'000 |
Weighted average number of shares |
Per share Pence |
|
Earnings £'000 |
Weighted average number of shares |
Per share Pence |
|
|
Profit for the year - attributable to owners of the parent |
18,149 |
|
|
|
16,479 |
|
|
|
|
Shares in issue |
|
46,497,038 |
|
|
|
46,399,931 |
|
|
|
Shares owned by the Employee Benefit Trust |
|
(367,660) |
|
|
|
(355,411) |
|
|
|
Basic EPS |
18,149 |
46,129,378 |
39.3 |
|
16,479 |
46,044,520 |
35.8 |
|
|
Dilutive share options outstanding |
- |
34,555 |
- |
|
- |
5,762 |
- |
|
|
Diluted EPS |
18,149 |
46,163,933 |
39.3 |
|
16,479 |
46,050,282 |
35.8 |
|
In addition to the above, the Group also calculates an EPS based on adjusted profit as the Board believes this to be a better measure to judge the progress of the Group, as discussed in note 1.
The following table reconciles the Group's profit to adjusted profit used in the numerator in calculating adjusted EPS:
|
|
2025 |
|
2024 |
|
||||
|
Adjusted
|
Earnings £'000 |
Weighted average number of shares |
Per share Pence |
|
Earnings £'000 |
Weighted average number of shares |
Per share Pence |
|
|
Profit for the year - attributable to owners of the parent |
18,149 |
|
|
|
16,479 |
|
|
|
|
Adjusting items (note 1) |
1,354 |
|
|
|
1,302 |
|
|
|
|
Adjusted profit -attributable to owners of the parent |
19,503 |
|
|
|
17,781 |
|
|
|
|
Adjusted Basic EPS |
19,503 |
46,129,378 |
42.3 |
|
17,781 |
46,044,520 |
38.6 |
|
|
Adjusted Diluted EPS |
19,503 |
46,163,933 |
42.2 |
|
17,781 |
46,050,282 |
38.6 |
|
4. Dividends per share
|
|
2025 |
|
2024 |
||
|
|
Per share |
|
|
Per share |
|
|
|
Pence |
£'000 |
|
Pence |
£'000 |
|
|
|
|
|
|
|
|
Final dividend paid - in respect of prior year |
4.2 |
1,939 |
|
4.0 |
1,842 |
|
Interim dividend paid - in respect of current year |
2.2 |
1,014 |
|
2.1 |
969 |
|
|
6.4 |
2,953 |
|
6.1 |
2,811 |
The Directors recommend the payment of a final dividend of 4.5 pence per share (2024: 4.2 pence per share) to be paid on 8 June 2026 to shareholders on the register on 1 May 2026; the ex-dividend date is 30 April 2026. This makes a total dividend for the year of 6.7 pence per share (2024: 6.3 pence per share).
5. Provisions
|
|
|
Dilapidations |
|
Warranty |
|
Total |
|
|
|
£'000 |
|
£'000 |
|
£'000 |
|
At 1 December 2024 |
|
346 |
|
3,256 |
|
3,602 |
|
Additional charge in the year |
|
- |
|
403 |
|
403 |
|
Utilisation of provision |
|
- |
|
(188) |
|
(188) |
|
Release of provision |
|
- |
|
(464) |
|
(464) |
|
Unwinding of discount |
|
39 |
|
- |
|
39 |
|
Exchange |
|
- |
|
(25) |
|
(25) |
|
At 30 November 2025 |
|
385 |
|
2,982 |
|
3,367 |
Provisions arise from potential claims on major contracts, sale warranties, and discounted dilapidations for leased property. Matters that could affect the timing, quantum and extent to which provisions are utilised or released, include the impact of any remedial work, claims against outstanding performance bonds, and the demonstrated life of the filtration equipment installed. The outflow of economic benefits in relation to warranty provisions is expected to be within one year, whilst the outflow on dilapidations is expected to be greater than one year.
|
|
|
2025 |
|
2024 |
|
Analysis of total provisions |
|
£'000 |
|
£'000 |
|
Current |
|
2,982 |
|
3,256 |
|
Non-current |
|
385 |
|
346 |
|
Net book value at 30 November |
|
3,367 |
|
3,602 |
6. Cash generated from operations
|
|
|
2025 £'000 |
|
2024 £'000 |
|
Operating profit |
|
24,464 |
|
22,797 |
|
Adjustments for: |
|
|
|
|
|
Depreciation of property, plant and equipment |
|
3,763 |
|
3,576 |
|
Depreciation of right-of-use assets |
|
2,604 |
|
2,201 |
|
Amortisation of acquired intangible assets |
|
1,633 |
|
1,743 |
|
Amortisation of other intangible assets |
|
155 |
|
185 |
|
Impairment of property, plant and equipment |
|
- |
|
16 |
|
Gain on exit of lease |
|
(180) |
|
- |
|
(Gain)/loss on disposal of assets |
|
(32) |
|
184 |
|
Fair value movement of derivatives through profit and loss |
|
(65) |
|
283 |
|
Share-based payments |
|
665 |
|
751 |
|
Operating cash flows before movement in working capital |
|
33,007 |
|
31,736 |
|
(Increase)/decrease in inventories |
|
(1,196) |
|
548 |
|
Increase in trade and other receivables |
|
(2,456) |
|
(7,161) |
|
Increase in trade and other payables |
|
2,259 |
|
2,876 |
|
Decrease in provisions |
|
(199) |
|
(27) |
|
Increase in working capital |
|
(1,592) |
|
(3,764) |
|
Post-employment benefits |
|
(2,201) |
|
(2,228) |
|
Cash generated from operations |
|
29,214 |
|
25,744 |
7. Events after the reporting date
Following the year-end, on 12 January 2026 the Group acquired 100% of the share capital of Drache Umwelttechnik GmbH ("Drache"). Founded in 1984 and headquartered in Diez, Germany, Drache is active in the development, manufacture, and distribution of filters, consumables, and equipment for the molten metal industry, and is a leading supplier to the aluminium filtration market. Drache will join the Group's Metal Melt Quality division, bringing complementary products and engineering experience, while expanding the division's global reach with a new European base alongside its American and Asian operations.
The acquisition is on a cash free, debt free basis and subject to an agreed level of working capital. Cash consideration of £17.8m was paid after the year-end in January 2026.
In accordance with the sale and purchase agreement, completion accounts are not required until after the date of approval of these financial statements. Adjustments have not yet been made to the net assets acquired to reflect their fair values, including the recognition of acquired intangible assets separable from goodwill. The provisional values for consideration and net assets acquired will be determined in future in accordance with IFRS 3 Business Combinations and the sale and purchase agreement. Due to the proximity of the acquisition date to the date these financial statements were authorised for issue, the initial accounting for the business combination is incomplete and so the disclosures required by IFRS 3 Business Combinations cannot be made at this stage.
8. Basis of preparation
Porvair plc is a public company limited by shares incorporated in the UK under the Companies Act 2006 and listed on the London Stock Exchange. The results for the year ended 30 November 2025 have been prepared in accordance with the Companies Act 2006 and UK-adopted International Accounting Standards. The financial information contained in this announcement does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information has been extracted from the financial statements for the year ended 30 November 2025, which have been approved by the Board of Directors and on which the Auditors have reported without qualification. The financial statements will be delivered to the Registrar of Companies after the Annual General Meeting. The financial statements for the year ended 30 November 2024, upon which the Auditors reported without qualification, have been delivered to the Registrar of Companies.
9. Annual general meeting
The Company's Annual General Meeting will be held at 11.00 a.m. on Tuesday 14 April 2026 at the offices of Burson Buchanan, Rose Court, 2 Southwark Bridge Road, London, SE1 9HS.
10. Responsibility statement
Each of the Directors confirms, to the best of their knowledge, that:
· the financial statements, on which this announcement is based, have been prepared in accordance with the Companies Act 2006 and UK-adopted International Accounting Standards, and give a true and fair view of the assets, liabilities, financial position, and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and
· the review of the business includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.
The Directors of Porvair are listed in the Porvair Annual Report & Accounts for the year ended 30 November 2024. Since the publication of the Annual Report for the year ended 30 November 2024, Lisa Anson joined the Board on 1 October 2025 and Sally Martin retired from the Board on 4 November 2025. Hooman Caman Javvi joined the Group on 6 January 2025 as Chief Executive designate and assumed the role of Chief Executive Officer on the retirement of Ben Stocks, following the Company's AGM on 15 April 2025. A list of current Directors is maintained on the Porvair plc website, www.porvair.com. The Annual Report & Accounts for the year ended 30 November 2025 will be made available in March 2026 on www.porvair.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.